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In Brief
Cholesterol is a prerequisite for growth of
cancer cells. Gabitova et al. show that
blockade of cholesterol biosynthesis at
the C4-demethylation step results in
suppression of tumor growth. Cholesterol
blockade leads to the accumulation of
sterol metabolites that activate nuclear
receptor LXRa and its transcriptional
targets, leading to an uncompensated
loss of cholesterol.
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